Nicholas J. Geraghty

Amyotrophic Lateral Sclerosis: Proteins, Proteostasis, Prions, and Promises

Luke McAlary, Yee Lian Chew, Jeremy S. Lum et al. · Frontiers in Cellular Neuroscience · 2020 · 43 citations · Full text

The P2X7 receptor antagonist Brilliant Blue G reduces serum human interferon-γ in a humanized mouse model of graft-<i>versus</i>-host disease

Nicholas J. Geraghty, Lisa Belfiore, Dalam Ly et al. · Clinical & Experimental Immunology · 2017 · 40 citations · Full text

Comparison of peripheral blood mononuclear cell isolation techniques and the impact of cryopreservation on human lymphocytes expressing CD39 and CD73

Ross J. Turner, Nicholas J. Geraghty, Jonathan G. Williams et al. · Purinergic Signalling · 2020 · 38 citations · Full text

Cell Therapy, Medicine, Immunology +7

The P2X7 receptor antagonist JNJ-47965567 administered thrice weekly from disease onset does not alter progression of amyotrophic lateral sclerosis in SOD1G93A mice

Diane Ly, Anjila Dongol, Peter Cuthbertson et al. · Purinergic Signalling · 2020 · 32 citations · Full text

Amyotrophic Lateral Sclerosis, Medicine, Sod1g93a Mice +8

Activation of the P2X7 receptor induces the rapid shedding of CD23 from human and murine B cells

Aleta Pupovac, Nicholas J. Geraghty, Debbie Watson et al. · Immunology and Cell Biology · 2014 · 30 citations